Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.